Tscan Therapeutics (TCRX) traded up 3.65 % during a 24 hours period ending at 07:01 AM Central Europe on Friday 30th. One Tscan Therapeutics stock can currently be bought for about USD 0.19 on popular exchanges. Current supply of Tscan Therapeutics stocks is 63.5 mn. Tscan Therapeutics has a current market capitalization of USD 13.5 mn and approximately USD 71.5 k worth of Tscan Therapeutics was traded on exchanges in the last 24 hours. Since last month end, Tscan Therapeutics has traded -37.42 % down. Simple moving average of last 200 days is at USD 0.86. The highest price of past 52 weeks was recorded at USD 1.48 on 11/03/2025. 52 weeks low was at USD 0.18 on 10/26/2026.
Here is how related stocks have performed in the past 24 hours:
Dyadic (DYAI) traded down -7.69 % and now trades at USD 0.36. Current market capitalisation for Dyadic is USD 15.8 mn.
Intelligent Protection Manag (IPM) traded down -0.58 % and now trades at USD 1.72. Current market capitalisation for Intelligent Protection Manag is USD 15.5 mn.
Tomi Environmental (TOMZ) traded up 10.74 % and now trades at USD 1.7. Current market capitalisation for Tomi Environmental is USD 16.2 mn.
Intrusion (INTZ) traded down -9.23 % and now trades at USD 0.59. Intrusion has a market capitalisation of USD 15.9 mn.
Aquabounty (AQB) traded up 11.11 % and now trades at USD 1.25. Aquabounty has a market capitalisation of USD 16 mn.
About Tscan Therapeutics
TScan Therapeutics, Inc. is a biotech company that specializes in developing T cell therapies for patients to unlock the potential of their human immune systems. The company operates globally, serving customers worldwide. You can find more information about their activities and offerings on their website at www.tscan.com , and they are traded on the Nasdaq stock exchange.